Comparative genomics of protein structure and function

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

Abstract

Comparative Genomics of Protein Structure-Function in Networks and Disease Clinical exome sequencing is increasingly frequent but still of limited impact on patient care and personalized medicine. Key difficulties keeping these data from being translated into therapeutic plans are that in each patient harmful mutations are few and seemlessly blended into the vast background of harmless ones. As a result, disease-causing genes are difficult to spot. Also, even when imputable genes are found their functions are typically unknown. We now tackle these problems by merging two lines of investigation that both model the evolution and propagation of biological information as a smooth process. In protein structures, smoothing has improved predictions of evolutionary important sites, functions and substrates. In networks, it has led to function predictions without need of structural knowledge. And, with respect to the genotype-phenotype relationship, it has led to an equation for the harmful action of coding mutations on fitness. Aim 1 now proposes to refine this equation to score the harm of coding mutations in order to uncover disease- causing genes and pathways. The focus will be on cancer given the ready availability of exome data from The Cancer Genome Atlas. In parallel, Aim 2 will develop new and general network-based techniques to decipher the role of proteins of interest. Aim 3 will experimentally validate select predictions of cancer-causing genes by testing in head and neck and lung cancer cell lines whether they behave as expected of tumor suppressors and oncogenes. This work should yield innovative, formal analyses of the genotype to phenotype relationship with direct applications to cancer genomics; it will unite molecular evolution and population genetics, whilst enabling the clinical interpretation of genome variations and the discovery of cancer genes that determine morbidity and mortality and eventually lead to novel therapeutics.